This probiotic combination shows promise as a preventive and therapeutic agent for oral health, especially in mitigating pathogenic bacterial growth and reducing inflammation in periodontal disease.

On November 6th, the 7th CIIE kicked off at the Shanghai National Convention and Exhibition Center. At the Bayer Health Consumer Products Exhibition Area, Bayer, Jiangnan University, and Weikang Probiotics jointly held IberoBiotics ® Celebrating the export of probiotics to ASEAN, IberoBiotics, a gut health probiotic product jointly developed and produced by three parties, was announced ® Successfully listed in Singapore this year, and plans to expand to more ASEAN countries in the future.

Animal model experiments show that a mixture of LA85 and BLa80 can alleviate the inflammation caused by H. pylori infection. The combination of these strains proves more effective in relieving inflammation than either strain alone.

The fermentation system of WECARE Probiotics Intelligent Manufacturing Factory has set an industry benchmark with the advantages of scale, intelligence, and refinement. The system integrates an intelligent and fully automated fermentation process, achieving full pipeline transportation of materials. It is equipped with a 30 ton ultra large capacity single fermentation tank, with a total fermentation capacity of up to 400 tons.

This probiotic patent focuses on a dual-strain formulation targeting osteoporosis improvement. The formulation contains Limosilactobacillus reuteri LR38 and Lacticaseibacillus rhamnosus LRa05, which together exhibit synergistic effects on bone health by mitigating bone density loss and decreasing osteoclastogenic factors.

Las Vegas, NV – The curtains officially opened on the much-anticipated SupplySide West 2024 exhibition in Las Vegas, marking a pivotal moment for the global natural, health, and innovative ingredients industry. At the heart of this prestigious event, WECARE shone brightly as the official category sponsor, commanding a prime presence at booth number 6643.